DexCom Is Up 90% Since January; Time To Sell?
- Thursday, May 14, 2020, 7:17
- Market
- Add a comment
DexCom a company best known for its continuous glucose monitoring system, has seen its stock outperform year-to-date, rising by almost 90%, compared to the broader S&P which is down ~10%. The company has been witnessing higher demand for its glucose monitoring devices…
About the Author
admin123 has written 23527 stories on this site.
